Form 4: DexCom Director Steven Altman Reports Changes in Beneficial Ownership

Steven Altman, a director at DexCom Inc., reported a transfer of shares to a family trust and the grant of restricted stock units.

Summary

• On May 8, 2025, Steven Altman, a director of DexCom Inc., filed a Form 4 to report changes in his beneficial ownership of the company's stock.
• Altman transferred 2,613 shares of common stock from direct ownership to the Steven R. and Lisa J. Altman Family Trust.
• He also received a grant of 5,037 restricted stock units (RSUs) that will vest on the earlier of May 8, 2026, or the date of DexCom's 2026 Annual Meeting of Stockholders.
• Following these transactions, Altman directly owns 5,037 shares and indirectly owns 58,630 shares through the family trust.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing, indicating standard corporate governance practices. The RSU grant is a positive sign, aligning management interests with shareholders.

Positives

• The grant of RSUs to a director aligns their interests with those of shareholders, incentivizing them to work towards the company's success.

Future Outlook

The RSUs will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2026 Annual Meeting of Stockholders.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The RSU grant aligns the director's interests with those of shareholders.

Key Dates

Keywords

Form 4, beneficial ownership, restricted stock units, RSU, DexCom, DXCM, Steven Altman, director, family trust